Achillion Pharmaceuticals has appointed Paul Firuta to the position of Executive Vice President and Chief Operating Officer, effective immediately.

Mr. Firuta, with 27 years of experience successfully building commercial organizations and launching products targeting rare diseases, will assume responsibility for leading Achillion’s commercial strategy and operations, market access, pharmaceutical sciences & manufacturing, project management and patient advocacy.